Thrivent Financial For Lutherans Coherus Bio Sciences, Inc. Transaction History

Thrivent Financial For Lutherans

$52.6 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$3.79 - $8.3 $37 - $83	-10 Reduced 0.02%	63,960 $273,000
Q1 2023 May 17, 2023	SELL	$5.89 - $10.52 $13,240 - $23,648	-2,248 Reduced 3.39%	63,970 $438,000
Q4 2022 Feb 08, 2023	SELL	$5.69 - $10.07 $2,668 - $4,722	-469 Reduced 0.7%	66,218 $524,000
Q3 2022 Nov 14, 2022	BUY	$7.17 - $13.87 $25,475 - $49,280	3,553 Added 5.63%	66,687 $641,000
Q2 2022 Aug 16, 2022	BUY	$5.86 - $13.23 $65,936 - $148,863	11,252 Added 21.69%	63,134 $457,000
Q1 2022 May 13, 2022	BUY	$10.92 - $16.41 $185 - $278	17 Added 0.03%	51,882 $670,000
Q4 2021 Feb 16, 2022	BUY	$15.81 - $18.99 $8,774 - $10,539	555 Added 1.08%	51,865 $828,000
Q3 2021 Nov 15, 2021	SELL	$12.68 - $17.79 $40,398 - $56,678	-3,186 Reduced 5.85%	51,310 $825,000
Q2 2021 Aug 19, 2021	BUY	$12.95 - $15.41 $24,268 - $28,878	1,874 Added 3.56%	54,496 $754,000
Q1 2021 May 17, 2021	BUY	$14.42 - $21.39 $2,047 - $3,037	142 Added 0.27%	52,622 $769,000
Q4 2020 Feb 16, 2021	BUY	$16.56 - $18.94 $5,464 - $6,250	330 Added 0.63%	52,480 $912,000
Q3 2020 Nov 10, 2020	BUY	$17.41 - $19.89 $19,220 - $21,958	1,104 Added 2.16%	52,150 $956,000
Q2 2020 Aug 12, 2020	BUY	$14.43 - $19.16 $736,593 - $978,041	51,046 New	51,046 $912,000
Q3 2018 Nov 15, 2018	SELL	$14.45 - $20.25 $840,079 - $1.18 Million	-58,137 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$10.25 - $17.45 $3,218 - $5,479	314 Added 0.54%	58,137 $814,000
Q1 2018 May 08, 2018	BUY	$9.1 - $13.7 $6,215 - $9,357	683 Added 1.2%	57,823 $639,000
Q3 2017 Nov 14, 2017	BUY	$11.1 - $14.5 $634,254 - $828,530	57,140	57,140 $762,000

Others Institutions Holding CHRS

# of Institutions

135

Shares Held

77.9M

Call Options Held

40.7K

Put Options Held

50.1K

Black Rock Inc. New York, NY

11.8M
Shares

$17.4 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

11.3M
Shares

$16.7 Million
0.0% of portfolio
Rubric Capital Management LP New York, NY

10.4M
Shares

$15.4 Million
0.3% of portfolio
Kohlberg Kravis Roberts & Co. L.P. New York, NY

3.04M
Shares

$4.49 Million
0.18% of portfolio
Ken Griffin Citadel Advisors LLC | Chicago, Il

2.86M
Shares

$4.23 Million
0.0% of portfolio

View Full List

About Coherus BioSciences, Inc.

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $115M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

More about CHRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.

Account